Table 1.
Gene symbol | anti-miR-C/NC | anti-miR-26a/NC | anti-miR-26b/NC | anti-miR-26a/b | siCTDSP1/anti-miR-C | siCTDSP2/anti-miR-C | siCTDSPL/anti-miR-C | anti-miR-26a/siCTDSP2 | anti-miR-26a/siCTDSPL | anti-miR-26b/siCTDSP1 |
---|---|---|---|---|---|---|---|---|---|---|
ACACA | 1.30 + 0.08 | 0.83 + 0.01* | 0.89 + 0.03* | 0.79 + 0.02* | 1.00 + 0.03 | 0.81 + 0.04* | 1.00 + 0.07 | 0.76 + 0.02# | 0.76 + 0.04 | 0.86 + 0.10 |
AGPAT6 | 1.06 + 0.05 | 0.95 + 0.03 | 1.04 + 0.09 | 0.94 + 0.08 | 1.00 + 0.10 | 0.91 + 0.06 | 1.07 + 0.05 | 1.02 + 0.02 | 1.24 + 0.05 | 1.05 + 0.06 |
CD36 | 0.82 + 0.01 | 0.71 + 0.06 | 0.59 + 0.03* | 0.55 + 0.06* | 1.00 + 0.05 | 0.95 + 0.05 | 0.86 + 0.04 | 0.78 + 0.05$ | 0.46 + 0.06#,$ | 0.54 + 0.04$ |
DGAT1 | 1.48 + 0.09 | 0.99 + 0.01* | 0.87 + 0.03* | 0.73 + 0.02** | 1.65 + 0.07 | 1.08 + 0.08* | 1.00 + 0.07* | 1.05 + 0.05 | 0.95 + 0.01 | 0.84 + 0.02$ |
FASN | 1.76 + 0.09 | 1.42 + 0.10 | 0.90 + 0.03** | 0.82 + 0.02** | 1.10 + 0.04* | 1.49 + 0.11 | 1.00 + 0.10* | 1.03 + 0.05#,$ | 1.23 + 0.04 | 0.81 + 0.05$ |
GPAM | 1.40 + 0.06 | 0.73 + 0.04** | 0.89 + 0.01* | 0.96 + 0.03* | 1.00 + 0.09 | 0.81 + 0.02* | 1.00 + 0.06 | 0.78 + 0.09 | 0.71 + 0.03 | 0.73 + 0.03# |
INSIG1 | 1.12 + 0.13 | 2.33 + 0.11* | 3.50 + 0.03** | 3.94 + 0.16** | 3.13 + 0.04 | 2.29 + 0.05 | 2.54 + 0.08** | 2.70 + 0.10$ | 2.97 + 0.13 | 3.15 + 0.08 |
LPIN1 | 1.30 + 0.05 | 0.85 + 0.09* | 0.84 + 0.04* | 0.84 + 0.04* | 1.00 + 0.01 | 1.16 + 0.09 | 1.19 + 0.02 | 0.74 + 0.01$ | 0.86 + 0.03 | 0.84 + 0.03 |
LXRA | 1.19 + 0.06 | 0.78 + 0.02* | 0.81 + 0.03* | 0.76 + 0.03* | 0.84 + 0.09 | 0.80 + 0.06* | 1.00 + 0.01 | 0.74 + 0.02 | 0.77 + 0.03$ | 0.69 + 0.03$ |
PLIN2 | 1.16 + 0.07 | 1.00 + 0.09 | 1.05 + 0.04 | 0.83 + 0.01* | 0.90 + 0.06 | 0.77 + 0.06* | 0.81 + 0.06* | 1.05 + 0.09 | 0.71 + 0.01 | 0.79 + 0 09 |
PNPLA2 | 1.24 + 0.08 | 1.06 + 0.11 | 0.99 + 0.04 | 0.90 + 0.04* | 0.82 + 0.09 | 2.81 + 0.16** | 1.69 + 0.09 | 1.51 + 0.11# | 2.56 + 0.10#,$ | 1.70 + 0.04#,$ |
PPARG | 0.82 + 0.10 | 0.61 + 0.06** | 0.54 + 0.03** | 0.60 + 0.02** | 0.61 + 0.03* | 0.98 + 0.02 | 0.86 + 0.07 | 0.56 + 0.02$ | 0.69 + 0.07 | 0.48 + 0.06 |
SCD1 | 1.24 + 0.07 | 0.64 + 0.05** | 0.75 + 0.01* | 0.57 + 0.03** | 1.00 + 0.05 | 0.73 + 0.01** | 1.13 + 0.07 | 0.87 + 0.07 | 0.87 + 0.03 | 0.89 + 0.06 |
SREBF1 | 1.62 + 0.03 | 1.45 + 0.07 | 0.87 + 0.08** | 0.71 + 0.03** | 0.96 + 0.06** | 1.03 + 0.07* | 1.00 + 0.02* | 0.91 + 0.03# | 0.94 + 0.09# | 0.71 + 0.03 |
GMEC were co-transfected with 120 nM oligonucleotides (60 nM each) and after 48 h post-transfection, the ACACA, AGPAT6, CD36, DGAT1, FASN, GPAM, INSIG1, LPIN1, LXRA, PLIN2, PNPLA2, PPARG, SCD1 and SREBF1 expression levels were quantified by quantitative real-time PCR. All experiments were performed in triplicate and repeated 3 times (n = 9). Values are presented as mean ± SEM;
P < 0.05,
P < 0.01 vs anti-miR-C/NC,
P < 0.05 vs anti-miR-26a/NC or anti-miR-26b/NC,
P < 0.05 vs siCTDSP1/anti-miR-C or siCTDSP2/ anti-miR-C or siCTDSPL/ anti-miR-C.